Page last updated: 2024-08-24

telmisartan and Neoplasms

telmisartan has been researched along with Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L1
Benard, F; Bennewith, KL; Cederberg, RA; Colpo, N; Firmino, NS; Franks, SE; Lee, CM; Lin, KS; Pan, J; Wadsworth, BJ1
Hosoda, A; Kohno, T; Masamichi, S; Matsumoto, Y; Toriyama, Y; Tsuji, T; Yoshida, Y1
Dudás, J; Ganswindt, U; Riechelmann, H; Skvortsov, S; Skvortsova, II; Steinbichler, TB1
Barrios, V; Escobar, C1
Albert, DH; Banfor, PN; Cox, BF; Davidsen, SK; Franklin, PH; Fryer, RM; Gintant, GA; Larson, KJ; Noonan, WT; Segreti, JA; Tapang, P; Widomski, DL1
Debanne, SM; Fang, JC; Rowland, DY; Simon, DI; Sipahi, I1
Chang, CH; Lai, MS; Lin, JW; Wu, LC1
Nuzum, DS; Olin, JL; Veverka, A1

Reviews

7 review(s) available for telmisartan and Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction

2015
Therapy resistance mediated by cancer stem cells.
    Seminars in cancer biology, 2018, Volume: 53

    Topics: ATP-Binding Cassette Transporters; Chemoradiotherapy; DNA Repair; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Stem Cells; Radiation Tolerance; Telmisartan

2018
An evaluation of the latest evidence relating to renin-angiotensin system inhibitors.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7

    Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Fumarates; Humans; Imidazoles; Meta-Analysis as Topic; Neoplasms; Oxadiazoles; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan; Tetrazoles

2013
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
    The Lancet. Oncology, 2010, Volume: 11, Issue:7

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Telmisartan

2010
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.
    Journal of hypertension, 2011, Volume: 29, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Case-Control Studies; Double-Blind Method; Humans; Hypertension; Irbesartan; Losartan; Neoplasms; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles

2011
Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Aug-01, Volume: 29, Issue:22

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Case-Control Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Humans; Incidence; Logistic Models; Losartan; Male; Middle Aged; Neoplasms; Odds Ratio; Publication Bias; Risk Assessment; Risk Factors; Taiwan; Telmisartan; Tetrazoles

2011
Risk of cancer associated with the use of angiotensin II-receptor blockers.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Nov-15, Volume: 68, Issue:22

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Male; Meta-Analysis as Topic; Neoplasms; Risk Assessment; Telmisartan

2011

Other Studies

3 other study(ies) available for telmisartan and Neoplasms

ArticleYear
Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.
    Cancer letters, 2020, 11-28, Volume: 493

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cancer-Associated Fibroblasts; Cell Line, Tumor; Collagen Type I; Fluorescent Dyes; Humans; Losartan; Mice; Neoplasms; Pentoxifylline; Positron-Emission Tomography; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy; Telmisartan; Tumor Hypoxia; Tumor Microenvironment; Xenograft Model Antitumor Assays

2020
Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
    Biological & pharmaceutical bulletin, 2020, Volume: 43, Issue:9

    Topics: Acute Kidney Injury; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Blood Pressure; Blood Urea Nitrogen; Calcium Channel Blockers; Cisplatin; Creatinine; Disease Models, Animal; Drug Synergism; Fibrosis; Humans; Injections, Intraperitoneal; Kidney; Male; Mice; Neoplasms; Severity of Illness Index; Telmisartan

2020
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:3

    Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Humans; Imidazoles; Indazoles; Lisinopril; Male; Mice; Mice, SCID; Neoplasms; Nifedipine; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Ramipril; Rats; Rats, Sprague-Dawley; Telmisartan; Thiophenes; Xenograft Model Antitumor Assays

2009